Antibodies
Login
Search   
Purified anti-BID Antibody
Purified anti-BID Antibody
650501 25 µg ¥21,000     
650502 100 µg ¥45,000     

Product Details

Clone: 1H11
Isotype: Rat IgG1
Reactivity: Human
Immunogen: Bacteria expressed His tagged full length recombinant protein
Formulation: This antibody is provided in phosphate-buffered solution, pH 7.2, 0.09% NaN3.
Preparation: The antibody was purified by affinity chromatography.
Concentration: 0.5 mg/ml
Storage & Handling: Upon receipt, store undiluted at 4°C.
Application:

WB - Quality tested
ELISA - Reported by the developer

Recommended Usage:

Each lot of this antibody is quality control tested by Western blotting. Western blotting, suggested working dilution(s): Use 1.0 µg antibody per ml antibody dilution buffer for each mini-gel. It is recommended that the reagent be titrated for optimal performance for each application.

COA:
Enter Lot#:   
Application
References:

1. Li H, et al. 1998. Cell 94:491. (WB ELISA)

Jurkat cell extracts were resolved
Jurkat cell extracts were resolved by electrophoresis, transferred to nitrocellulose, and probed with anti-BID antibody (clone 1H11). Proteins were visualized using a goat anti-rat IgG secondary conjugated to HRP and chemiluminescence detection.


Compare all formats



Description:

BID, a BH3 interacting domain death agonist is a member of the Bcl-2/Bcl-xL family. BID can form a heterodimer with either agonist BAX or antagonist Bcl-2. It is a mediator of mitochondrial damage induced by Caspase-8 (CASP8). After the cleavage by CASP8, the COOH-terminal part translocates to mitochondria and induces cytochrome c release, which in turn activates downstream caspases. Multiple alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been defined.

Other Names: BH3 domain-only protein, BH3 interacting domain death agonist
Structure: 195 aa encodes a 22 kD protein. It contains only BH3 domain, not the BH1, BH2, and BH4 domains found in other Bcl-2 family members.
Distribution: Cytoplasmic, inside mitochondria once activated.
Function: Activated by Caspase 8 in response to Fas/TNF-R1 death receptor signals.
Ligand Receptor: Caspase-8, BAK
Antigen
References:

1. Wang K, et al. 1996. Genes Dev. 10:2859.
2. Luo X, et al. 1998. Cell 94:481.
3. Yin XM, et al. 1999. Nature 400:886 .
4. Strasser A, et al. 2009. Immunity 30:180.

GeneID: 637
Latest Publications: View the latest BID articles on HighwirePress.com
UniProt: View information about BID on UniProt.org
Keywords: Purified anti-BID, 1H11, Purified, BH3 domain-only protein, BH3 interacting domain death agonist, Human, Immunology, Antibodies
Related Products

DescriptionCloneApplications
HRP Goat anti-rat IgG (minimal x-reactivity)Poly4054ELISA, WB, IHC

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
x
Compare Data Across All Formats
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.

  • Purified anti-BID
    Jurkat cell extracts were resolved

    Jurkat cell extracts were resolved by electrophoresis, transferred to nitrocellulose, and probed with anti-BID antibody (clone 1H11). Proteins were visualized using a goat anti-rat IgG secondary conjugated to HRP and chemiluminescence detection.

x
Copyright © 2012 BioLegend, Inc. All rights reserved.